Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 11:23 AM 2012  
VRX ELN ALKS PETS ACUR FLML 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for HSP

Hospira quote and profile

    
32.38
  
STOCK
 0.40   Macroaxis: 1.25 Up   1.25%  
 26.92 Year To Date 57.25 
 31.94 Trading Day  32.56 

Diversification Suggestion

Use Hospira to enhance returns of your portfolios. The stock experiences large bullish trend

1 Month Beta ..........

1.25
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Hospira will likely underperform.
Hospira Inc. Large Beta
HSP United States AMEX
Hospira Inc.
 
Trade Hospira
Current Valuation6.47 B
Shares Outstanding165.14 M
Number of Shares Shorted11.35 M
Revenue4.02 B
 thisGreen HSP HSP agains markets  1.25 % Macroaxis: change 1.25 Moved Up  
 
 United States NASDAQ   0.07 % Macroaxis: 0.07 Moved Down  
 
 United States SP 500   0.22 % Macroaxis: 0.22 Moved Down  
 
 United States NYSE   0.24 % Macroaxis: 0.24 Moved Down  
 

Hospira Leadership

Michael Ball CEO, Director and Member of Science, Technology and Quality Committee
F Ball CEO, Director
John Staley Chairman, Member of Governance and Public Policy Committee, Member of Search Committee and Member of Science, Technology and Quality Committee
Richard Davies Senior Vice President Chief Commercial Officer, MBA

Hospira Price and Market Media

The median price of Hospira for the period between Thu, Apr 26, 2012 and Sat, May 26, 2012 is 33.34 with a coefficient of variation of 3.59. The daily time series for the period is distributed with a sample standard deviation of 1.2, arithmetic mean of 33.45, and mean deviation of 1.03. The Stock received substential amount of media coverage during this period.
Hospira         Market
Price Growth (%)
 
Timeline
Hospira_Reports_First-Quarter_2012_ResultsHospira Reports First-Quarter 2012 Results05/01/2012Macroaxis: News
Hospira_Convenes_Its_2012_Annual_Meeting_of_ShareholdersHospira Convenes Its 2012 Annual Meeting of Shareholders05/09/2012Macroaxis: News
Hospira_Recalls_Pain_Drug_Cartridges_On_Over-Fill_ConcernsHospira Recalls Pain Drug Cartridges On Over-Fill Concerns05/14/2012Macroaxis: Wall Street Journal
Dr_Robin_Smith_Explaining_NeoStem__A_True_Value_PlayDr. Robin Smith Explaining NeoStem: A True Value Play05/18/2012Macroaxis: Seeking Alpha News

Hospira Summary

Hospira Inc. [HSP] is traded on American Stock Exchange in USA. It is located in Lake Forest, IL and employs 15,000 people. The company currently falls under 'Mid-Cap' category with total capitalization of 5.35 B. Hospira Inc. runs under Healthcare sector within Drug Delivery industry. This company has 165.14 M outstanding shares of which 11.35 M shares are currently shorted by investors with about 8.5 days to cover shorted positions.

Hospira Liquidity

HOSPIRA INC has about 655.9 M in cash with 515.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.97.
The company has 1.78 B in debt with debt to equity (D/E) ratio of 0.59 which is OK given its current industry classification. Hospira Inc. has Current Ratio of 2.92 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Discuss Hospira quote and profile

       
       
    
    
Hospira
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Hospira Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    

Promote Hospira

    
Follow Hospira with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Hospira to your reader
 
Get social with Hospira
 Get social with Hospira 
Share Toggle social options for Hospira
    

Add Hospira to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

Hospira Research Report

    
    

Hospira Executives

Thomas Werner CFO and Sr. VP of Fin.

Hospira Directors

Mark Wheeler Independent Director
William Dempsey Independent Director
Connie Curran Independent Director
Heino Prondzynski Independent Director
Irving Bailey Lead Independent Director



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting